Regional differences in expression of specific markers for human embryonic stem cells

Reproductive BioMedicine Online

Volumn 15, Issue 1, 2007, Pages 89-98

  Laursen, Steen B ^a   Møllgard, Kjeld ^b   Olesen, Christian ^a   Oliveri, Roberto S ^a   Brøchner, Christian B ^b   Byskov, Anne Grete ^a   Andersen, Anders Nyboe ^a   Høyer, Poul Erik ^b   Tommerup, Niels ^c   Andersen, Claus Yding ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Human embryonic stem cells; NANOG; OCT4; Pluripotency marker; SSEA4; TRA 1 60

Indexed keywords

BIOLOGICAL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; REX PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4;

ARTICLE; BLASTOCYST; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34547456530     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60697-9     Document Type: Article

References (26)

1. Assou S, Lecarrour T, Tondeur S et al. 2007 A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25, 961-973.
2. Brandenberger R, Wei H, Zhang S et al. 2004 Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nature Biotechnology 22, 707-716.
3. Chambers I, Colby D, Robertson M et al. 2003 Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
4. Cowan CA, Klimanskaya I, McMahon J et al. 2004 Derivation of embryonic stem-cell lines from human blastocysts. New England Journal of Medicine 350, 1353-1356.
5. Davila JC, Cezar GG, Thiede M et al. 2004 Use and application of stem cells in toxicology. Toxicology Science 79, 214-223.
6. Draper JS, Smith K, Gokhale P et al. 2004 Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nature Biotechnology 22, 53-54.
7. Gerami-Naini B, Dovzhenko OV, Durning M et al. 2004 Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology 145, 1517-1524.
8. Hansis C 2006 Totipotency, cell differentiation and reprogramming in humans. Reproductive BioMedicine Online 13, 551-557.
9. Heins N, Englund MC, Sjoblom C et al. 2004 Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22, 367-376.
10. Hoffmann LM, Carpenter MK 2005 Characterization and culture of human embryonic stem cells. Nature Biotechnology 23, 699-708.
11. Hubner K, Fuhrmann G, Christenson LK et al. 2003 Derivation of oocytes from mouse embryonic stem cells. Science 300, 1251-1256.
12. Inzunza J, Gertow K, Stromberg MA et al. 2005 Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23, 544-549.
13. Matin MM, Walsh JR, Gokhale PJ et al. 2004 Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22, 659-668.
14. McNeish J 2004 Embryonic stem cells in drug discovery. Nature Review Drug Discovery 3, 70-80.
15. Mitsui K, Tokuzawa Y, Itoh H et al. 2003 The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
16. Nichols J, Zevnik B, Anastassiadis K et al. 1998 Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391.
17. Olesen C, Nyeng P, Kalisz M et al. 2007 Global gene expression analysis in fetal mouse ovaries with and without meiosis and comparison of selected genes with meiosis in the testis. Cell and Tissue Research 328, 207-221.
18. Palmieri SL, Peter W, Hess H et al. 1994 Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Developmental Biology 166, 259-267.
19. Pan G, Li J, Zhou Y et al. 2006 A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB Journal 20, 1730-1732.
20. Reubinoff BE, Peta MF, Fong CY et al. 2000 Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnology 18, 399-404.
21. Richards M, Tan SP, Tan JH et al. 2004 The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22, 51-64.
22. Shimozaki K, Nakashima K, Niwa H et al. 2003 Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures. Development 130, 2505-2512.
23. Stewart MH, Bossé M, Chadwick K et al. 2006 Clonal isolation of hESCs reveal heterogeneity within the pluripotent stem cell compartment. Nature Methods 3, 807-815.
24. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. 1998 Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
25. Yeom YI, Fuhrmann G, Ovitt CE et al. 1996 Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122, 881-894.
26. Zeng X, Miura T, Luo Y et al. 2004 Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22, 292-312.